Cy3 Goat Anti-Human IgG (H+L) Antibody: Atomic Facts & Benchmarks for Fluorescent Immunoassays

Executive Summary: The Cy3 Goat Anti-Human IgG (H+L) Antibody (APExBIO, SKU: K1208) is an affinity-purified secondary antibody conjugated to Cy3, enabling detection of human IgG with excitation at 552 nm and emission at 565 nm (APExBIO). It is generated by immunizing goats with pooled human IgG and purified via immunoaffinity chromatography, ensuring high specificity and minimal cross-reactivity (internal dossier). This antibody amplifies assay signals by binding multiple times to primary antibodies, enhancing sensitivity in immunofluorescence, IHC, flow cytometry, and ELISA (Zhao et al., 2025). It is supplied at 1 mg/mL in a glycerol/PBS/BSA/NaN₃ buffer, stable for 12 months at −20 °C with light protection. The reagent is validated for robust signal amplification and multiplexing in translational and diagnostic research workflows (internal workflow article).

Biological Rationale

Antibody-based detection is central in immunology, virology, and translational medicine. Human IgG is the predominant serum immunoglobulin and a key marker in infection, vaccination, and immune response studies (Zhao et al., 2025). Secondary antibodies, such as the Cy3 Goat Anti-Human IgG (H+L) Antibody, bind to primary human IgG antibodies, enabling visualization or quantification of targets. Cy3 conjugation provides a bright, photostable fluorescent signal for sensitive detection. The need for robust, multiplexed, and reproducible immunoassays has driven development of reagents like the K1208 kit (APExBIO product page).

Mechanism of Action of Cy3 Goat Anti-Human IgG (H+L) Antibody

The Cy3 Goat Anti-Human IgG (H+L) Antibody is generated by immunizing goats with pooled human immunoglobulins, targeting both heavy (H) and light (L) chains. The antibody is affinity-purified using antigen-coupled agarose beads to maximize specificity. The Cy3 fluorochrome is covalently conjugated to the antibody, providing excitation at 552 nm and emission at 565 nm (APExBIO). When used as a secondary antibody, it binds to the Fc and Fab regions of human IgG primary antibodies, amplifying the detection signal. Each primary antibody can be recognized by several Cy3-conjugated secondary antibodies, increasing fluorescence intensity and assay sensitivity (strategic roadmap). Cy3 is stable under recommended storage and light-protected conditions.

Evidence & Benchmarks

• Affinity-purified secondary antibody exhibits <1% cross-reactivity with non-human immunoglobulins (see Table S2, DOI).
• Fluorescent signal observed at 565 nm emission in ICC/IF and IHC up to 1:500 dilution, maintaining S/N >10 over autofluorescence in human tissue sections (Fig. 2b, DOI).
• Stable for 12 months at −20 °C with <10% loss in fluorescence intensity (manufacturer data, APExBIO).
• Compatible with ELISA, providing <5% CV in inter-assay reproducibility (see Materials/Methods, internal dossier).
• Validated for multiplexed immunofluorescence with other fluorophores, provided spectral separation is maintained (see Supplementary Protocols, workflow article).
• Low background staining when blocking with 1% BSA in PBS, as confirmed in paraffin-embedded tissue (Fig. 3c, application review).

Applications, Limits & Misconceptions

The Cy3 Goat Anti-Human IgG (H+L) Antibody is validated for multiple core applications:

• Immunofluorescence (ICC/IF): Detects human IgG in cultured cells with high sensitivity (Zhao et al., 2025).
• Immunohistochemistry (IHC-Fr, IHC-P): Enables detection in frozen and paraffin-embedded human tissues; optimal results with 1:250–1:500 dilutions (internal dossier).
• Flow Cytometry: Allows fluorescence-based sorting of cells bound by human IgG antibodies (strategic roadmap).
• ELISA: Provides quantitative detection of human IgG; compatible with standard colorimetric or fluorescent plate readers (workflow article).

Common Pitfalls or Misconceptions

• Not species universal: This reagent detects human IgG only; cross-reactivity with non-human IgG is <1% but not zero (DOI).
• Not suitable for live-cell imaging: Contains sodium azide, which is cytotoxic (APExBIO).
• Not recommended for use with anti-goat primary antibodies: May cross-react due to host species (internal article).
• Photobleaching risk: Cy3 is sensitive to strong light; always protect during handling and storage (workflow article).
• Signal saturation: Excess secondary antibody may cause high background; titration is necessary for optimal results (internal dossier).

Workflow Integration & Parameters

For optimal results, the Cy3 Goat Anti-Human IgG (H+L) Antibody should be diluted 1:250–1:1,000 in PBS with 1% BSA. Incubate for 1 hour at room temperature or overnight at 4 °C. Wash extensively to reduce background. Use appropriate filters for Cy3 (excitation 550–555 nm, emission 560–570 nm). Store at 4 °C for short term (<2 weeks) or aliquot and freeze at −20 °C for long-term use. Avoid repeated freeze-thaw cycles. For multiplexing, ensure minimal overlap with other fluorophores. For detailed troubleshooting and advanced applications, see the internal workflow article (here), which this article extends by focusing on atomic, peer-reviewed performance metrics. For comparative mechanism insights, see the benchmarks dossier (here), which this article updates with new stability data and DOI-based validation.

Conclusion & Outlook

The Cy3 Goat Anti-Human IgG (H+L) Antibody from APExBIO is a rigorously benchmarked, Cy3-conjugated secondary antibody for human IgG detection, offering robust signal amplification and broad application compatibility. Its atomic, verifiable performance parameters support sensitive, reproducible immunoassays across translational and diagnostic workflows. The reagent's stability, specificity, and multiplexing capacity make it a cornerstone for next-generation immunofluorescence, immunohistochemistry, flow cytometry, and ELISA (APExBIO product). For strategic guidance on integrating this tool into orthopoxvirus or infectious disease antibody studies, see the thought-leadership article (here), which this article clarifies by providing atomic, DOI-linked benchmarks. Future advances may include further subclass specificity and expanded fluorochrome options.